Gene Therapy has emerged as a remarkable breakthrough in medical science. It can treat a vast and extensive range of diseases as it targets the underlying root cause by tracing it back to particular defective genes.
Since the first attempt at the modification of genes in 1980, medical science has come a long way. As such, when integrated with monoclonal antibody (mAb) therapies, gene therapy becomes all the more potentially effective since antibody-based therapies have proved to be revolutionary in healthcare in the recent past.
Antibody-based therapies target a specific molecule or cell, and by combining it with gene therapy, medical scientists aim to improve their effectiveness in treating the disease.
In this write-up, we will glance at the potential of gene therapy in enhancing monoclonal antibody therapies and how it could improve the future of healthcare in general.
Let us first look at the basics of genetic modification and monoclonal antibody therapies and understand how researchers are interconnecting them to discover newer ways of treatment.
Gene Therapy: Explained in Brief
Gene Therapy focuses on the genetic modification of cells to treat a particular disease. It involves repairing or reconstructing the defective genetic materials in the cells responsible for a disease by either introduction (gene addition), modification (gene editing or mutation repair), or deletion (gene silencing) of genes.
The chief aim is to address and eliminate the root cause of the disease at a genetic level. It has proven to be a potentially effective and long-lasting treatment solution. In some cases, it can cure the disease entirely.
It works on the fundamental principle of introducing a therapeutic gene into the patient’s cells, thereby replacing the missing or faulty genes or perhaps silencing (rendering inactive) the genes causing a rapid progression of the disease in the body.
Depending on the requirement of gene correction, different methods and types of gene therapy are applied, namely, ex-vivo, in-vivo, in-situ, and so on.
There are a number of gene therapy service providers offering cutting-edge technologies and expertise all around the country, especially in California, a hub of innovation in medical research and biotechnology.
Gene therapy services in California and elsewhere are playing a pivotal role in advancing the field of genetic engineering, microbiology, and minimally invasive treatments of complex diseases.
Understanding Monoclonal Antibody (mAb) Therapies
This is a type of targeted treatment where specific antibodies (proteins produced by the immune system to fight bacteria and viruses) are bound to particular diseased molecules or cells.
The process involves isolating a specific immune cell and fusing it with the diseased cell to form a hybridoma, which produces large quantities of the desired monoclonal antibodies. When the number of antibodies is sufficient and large enough, they can outnumber, attack, and eventually defeat the diseased cells.
Both gene therapy and monoclonal antibody therapies have effectively cured many diseases individually. However, the new efforts in medical science to combine them both are an exciting avenue because of the potential that gene therapy holds in making monoclonal antibody therapies more effective and successful.
How Can Gene Therapy Enhance Monoclonal Antibody Therapies?
Latest experiments and research reveal that gene therapy can help remove the limitations of monoclonal antibody therapies and make them more effective in treating complex diseases such as cancer, inflammation, and certain immune diseases.
When used in combination, they are also often referred to as Antibody Gene Therapy, and amongst its several possible advantages, the following stands out to be the most obvious.
1. Enhances Precision in Targeting and Specificity of Monoclonal Antibodies
When the genes responsible for producing the antibodies (immune proteins) are modified through gene therapy, the newly formed antibodies can have an enhanced binding affinity or modified specificity that helps target the diseased cells more efficiently.
It can also assist the mAb in reaching the target tissues with more precision and accuracy, thereby increasing the chances of corrective antibody binding.
2. Enhancing the Therapeutic Efficacy of Antibodies
The genes directly involved in the clearance of antibodies can be modified through gene editing techniques. It prolongs their circulation time and enhances their therapeutic effectiveness.
3. Increase the Binding Quantity of Antibodies
Gene therapy can increase the production of target molecules in cells or tissues, enhancing the possible number of binding sites or locations for the antibodies, and increasing the overall effectiveness of the treatment.
4. Combination Therapies
They can create a synergistic effect when used in conjunction with each other. For instance, genes can be introduced with encoded immune-modulating proteins, like cytokines, which can enhance the immune response leading to a more robust and targeted therapeutic response.
5. Overcome Resistance
Genetic modification techniques can correct or bypass the genetic resistance formed due to mutations or alterations in the target molecule, thereby rendering the monoclonal antibodies effective against resisting cells.
6. Personalized Treatment
Customizing genetic modifications using gene editing techniques to correct or modify molecules based on an individual’s gene expression enhances the compatibility and effectiveness of monoclonal antibody therapies.
Wrap Up
Gene therapy has emerged as a revolutionary approach to treating various complex diseases, coupled with the potential to enhance the efficacy of monoclonal antibody therapies. It can augment the targeting, delivery, and overall effectiveness of monoclonal antibodies by addressing the genetic basis of the particular disease.
Antibody gene therapy services in California and elsewhere around the country have contributed significantly to the steady progress of genetic engineering and medical sciences, ultimately benefiting humanity and human progress worldwide.
